Tag Archives: TXMD

Hot Stocks To Own Right Now

Facebook COO Sheryl Sandberg plans to donate all of her shares in SurveyMonkey to charity when it goes public.

The “Lean In” author owns 9.9% of the company. She joined the startup’s board after her late-husband Dave Goldberg died suddenly while on vacation in Mexico in 2015. Goldberg was the CEO.

SurveyMonkey revealed the planned donation in its IPO filing on Wednesday.

“Ms. Sandberg plans to donate all shares beneficially owned by her (or the proceeds from the sale thereof) to the Sheryl Sandberg and Dave Goldberg Family Foundation as part of fulfilling their philanthropic commitment to the Giving Pledge,” the filing said.

The Giving Pledge is an initiative created Warren Buffett and Bill and Melinda Gates to encourage the wealthy to donate some of their money to charitable causes.

Sandberg’s foundation supports her causes Lean In and Option B. The former creates programs that “advance opportunities for all women” and the latter supports people deal with grief after a loss, according to the website.

Hot Stocks To Own Right Now: TherapeuticsMD, Inc.(TXMD)

TherapeuticsMD, Inc., incorporated on July 20, 2010, is a women’s healthcare product company. The Company’s segment is creating and commercializing products for women. The Company is focused on conducting clinical trials necessary for regulatory approval and commercialization of advanced hormone therapy pharmaceutical products. The Company’s drug candidates used in its clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis and vaginal discomfort. The Company’s drug candidates are created using its SYMBODA hormone technology, which enables the administration of hormones with high bioavailability alone or in combination. The Company manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter (OTC) vitamins.

The Company manufactures and distributes its prescription and OTC product lines, consisting of prenatal vitamins, iron supplements, and natural menopause relief products under its vitaMedMD brand name, and authorized generic formulations of some of its prescription prenatal vitamin products under BocaGreenMD Prena1 name. The Company offers prescription prenatal vitamin product under its branded vitaMedMD name as vitaPearl and under its authorized generic Prena1 name as Prena1 Pearl, which features a combination of FOLMAX, FePlus and pur-DHA. The Company’s product line includes vitaTrue, vitaPearl, vitaMedMD Plus, vitaMedMD One Prenatal Multivitamin, vitaMedMD Plus Rx Prenatal Multivitamin, vitaMedMD One Rx Prenatal Multivitamin, vitaMedMD RediChew Rx Prenatal Multivitamin, vitaMedMD Iron 21/7, itaMedMD Menopause Relief with Lifenol Plus Bone Support, vitaMedMD Vitamin D3 50,000 IU, BocaGreenMD Prena1 Pearl and BocaGreenMD Prena1 Chew.

The Company’s vitaTrue is a prenatal vitamin and is targeted at health conscious consumers. vitaTrue contains a complete multivitamin with approximately 16 essential vitamins ! and minerals and over 300 milligrams (mg) of plant based docosahexaenoic acid, or DHA. vitaTrue is fish, gluten, lactose and sugar free. vitaPearl is a prenatal vitamin. vitaPearl delivers approximately 14 vitamins and minerals plus 200 milligrams of DHA, as par-DHA, providing support for pregnancy and nursing. vitaMedMD Plus is a once-daily, two pill combo pack that contains a multivitamin with approximately 16 essential vitamins and minerals and 300 milligrams of plant-based DHA. vitaMedMD One is a single-dose daily multivitamin that provides approximately 14 vitamins and minerals and 200 milligrams of plant-based DHA. Each softgel also features 975 micrograms of folic acid. vitaMedMD Plus Rx is a once-daily, two pill combo prescription product containing one prenatal vitamin tablet with Quatrefolic, and one plant-based DHA 300 milligrams capsule. vitaMedMD One Rx is a prescription product with a single-dose daily multivitamin that provides approximately 14 vitamins and minerals, Quatrefolic and 200 milligrams of plant-based DHA. vitaMedMD RediChew Rx is a prescription, vanilla-flavored chewable tablet containing Folmax, vitamin D3, vitamin B2, vitamin B6 and vitamin B12. vitaMedMD RediChew Rx is designed for women who have difficulty in swallowing tablets or softgels, or are experiencing nausea and morning sickness. vitaMedMD Iron 21/7 is an iron replacement supplement with a three weeks-on/one week-off dosing schedule intended to maximize absorption and enhance tolerability. It is formulated with 150 milligrams of chelated iron to help improve tolerability and limit typical side effects associated with iron replacements. Each single tablet serving also includes 800 micrograms of folic acid, plus vitamins C and B12, and succinic acid to aid in absorption.

The Company’s vitaMedMD Menopause Relief with Lifenol Plus Bone Support offers a natural treatment for hot flashes, night sweats and mood disturbances. Each single tablet dosage delivers 120 milligrams of Lifenol, a female hops extract ! recognize! d for its potency and support in alleviating hot flashes, plus plant phytoestrogens. It also includes calcium and vitamin D3 for added bone support. vitaMedMD Vitamin D3 50,000 IU is a dietary supplements provided in a gel capsule that helps to maintain beneficial levels of vitamin D in the body. vitaMedMD Vitamin D3 50,000 IU is ideal for pregnant, breastfeeding, and menopausal women to sustain adequate levels of vitamin D. BocaGreenMD Prena1 Pearl is an authorized generic of vitaPearl, a complete prenatal vitamin in one tiny pearl. BocaGreenMD Prena1 Chew is an authorized generic of vitaMedMD RediChew Rx, a prescription, single daily easy-to-chew, vanilla-flavored, chewable tablet. The Company’s hormone therapy drug candidates include TX-001HR, TX-002HR, TX-003HR and TX-004HR. TX-001HR is an oral combination of progesterone and estradiol. TX-002HR is a natural progesterone formulation for the treatment of secondary amenorrhea without the potentially allergenic component of peanut oil. TX-003HR is a natural estradiol formulation. TX-004HR is an applicator-free vaginal estradiol softgel drug candidate for the treatment of vulvar and vaginal atrophy (VVA) in post-menopausal women with vaginal linings that do not receive enough estrogen.

The Company competes with Pfizer, TEVA, BARR, Noven, Actavis, Akorn and AbbVie.

Advisors’ Opinion:

  • [By Motley Fool Transcribing]

    TherapeuticsMD, Inc. (NASDAQ:TXMD) Q4 2018 Earnings Conference CallFeb. 21, 2019 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    TherapeuticsMD Inc (NASDAQ:TXMD) has earned a consensus rating of “Buy” from the seven analysts that are presently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $17.33.

  • [By Cory Renauer]

    Shares of TherapeuticsMD (NASDAQ:TXMD), a biopharmaceutical company focused on women’s health, jumped 37.8% higher in January, according to data from S&P Global Market Intelligence. Investors were glad to hear the company’s new estradiol treatment for dyspareunia due to menopause is off to a better start than originally expected.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on TherapeuticsMD (TXMD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Stocks To Own Right Now: Turkcell Iletisim Hizmetleri AS(TKC)

Turkcell Iletisim Hizmetleri A.S. engages in establishing and operating a global system for mobile communications network in Turkey. It provides mobile voice, and Internet services over its mobile communications network; voice services, which include wireless telephone services on a prepaid and postpaid basis; mobile Internet and 3G services; consumer services; Telco services; TV and video services; music services; infotainment services; social community and other services; and mobile financial services The company also offers Turkcell enablers and platforms; corporate (B2B); corporate telco; authentication; location based; mobile marketing; machine-to-machine communications; and international roaming services. In addition, it provides Mobile Signature, a GSM service that enables customers to sign electronic documents and transactions with a legally-accepted digital signature using GSM SIM cards; and Mobile Billboard, which enables brands to reach their targeted customers . As of December 31, 2010, the company had approximately 23.3 million prepaid subscribers and 10.1 million postpaid subscribers. It sells its products and services through its distribution network consists of distributors, Turkcell distribution centers, corporate solution centers, non exclusive dealers, Turkcell communication centers, Turkcell stores, and consumer electronic Chains, as well as points of sale for prepaid airtime, including ATMs, POS, Web, call centers, supermarkets, and kiosks. The company was founded in 1993 and is headquartered in Istanbul, Turkey. Turkcell Iletisim Hizmetleri AS is a subsidiary of Turkcell Holding A.S.

Advisors’ Opinion:

  • [By Logan Wallace]

    Turkcell Iletisim Hizmetleri A.S. (NYSE:TKC) and CHORUS LTD/S (OTCMKTS:CHRYY) are both computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

  • [By Logan Wallace]

    WARNING: “Turkcell Iletisim Hizmetleri A.S. (TKC) Trading Down 8.4% After Earnings Miss” was first published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece on another domain, it was stolen and reposted in violation of United States & international copyright & trademark laws. The original version of this piece can be accessed at www.tickerreport.com/banking-finance/4169538/turkcell-iletisim-hizmetleri-a-s-tkc-trading-down-8-4-after-earnings-miss.html.

  • [By Rich Smith]

    Shares of Turkish telecom Turkcell Iletisim Hizmetleri (NYSE:TKC) plummeted 10% to close at $4.42 per share on Thursday — then proceeded to slide more after-hours. Perhaps worse for investors trying to figure out how to react to this news: There was no obvious reason for the decline.

  • [By Rich Smith]

    Turkish telco Turkcell Iletisim Hizmetleri (NYSE:TKC)closed up 11.6% on Thursday after the country’s central bank announced a big boost to interest rates — 24%, or 6.25 percentage points more than previously — boosting the Turkish lira’s value against the U.S. dollar for the third straight day.

Hot Stocks To Own Right Now: Sportsman's Warehouse Holdings, Inc.(SPWH)

Sportsmans Warehouse Holdings, Inc., together with its subsidiaries, operates as an outdoor sporting goods retailer in the United States. The company offers camping products, including backpacks, camp essentials, canoes and kayaks, coolers, outdoor cooking equipment, sleeping bags, tents, and tools; and clothing products comprising camouflage, jackets, hats, outerwear, sportswear, technical gear, and work wear. Its stores also provide fishing products consisting of bait, electronics, fishing rods, flotation items, fly fishing products, lines, lures, reels, tackle, and small boats; and foot wear products that include hiking boots, socks, sport sandals, technical footwear, trail shoes, casual shoes, waders, and work boots. In addition, the company offers hunting and shooting products, including ammunition, archery items, ATV accessories, blinds and tree stands, decoys, firearms, reloading equipment, and shooting gear; and optics, electronics, and accessories comprising gift items, GPS devices, knives, lighting, optics, and two-way radios. Further, its stores provide archery technician services, fishing-reel line winding, gun bore sighting and scope mounting, and other services, as well as issues hunting and fishing licenses. Additionally, the company offers various private label offerings under the Rustic Ridge, Killik, Vital Impact, Yukon Gold, Lost River, and Sportsmans Warehouse brands. As of January 30, 2016, the company operated 64 stores in 19 states. Sportsmans Warehouse Holdings, Inc. was founded in 1986 and is headquartered in Midvale, Utah.

Advisors’ Opinion:

  • [By Motley Fool Transcribing]

    Sportsman’s Warehouse Holdings (NASDAQ:SPWH) Q4 2018 Earnings Conference CallMarch 28, 2019 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Rich Smith]

    Sportsman’s Warehouse Holdings (NASDAQ:SPWH) reported earnings for its fiscal Q2 2018 this morning, and it seems investors liked what they had to say. Shares of the Midvale, Utah-based retailer of outdoor products are up 8.9% as of 2 p.m. EDT on news that it beat analyst earnings estimates last quarter.

Hot Stocks To Own Right Now: Ubiquiti Networks, Inc.(UBNT)

Ubiquiti Networks, Inc. provides networking products and solutions for service providers and enterprises worldwide. Its service provider product platforms provide carrier-class network infrastructure for fixed wireless broadband, wireless backhaul systems, and routing; and enterprise product platforms offer wireless LAN infrastructure, video surveillance products, VOIP phones, switches, and machine-to-machine communication components. The companys products and solutions include high performance radios, antennas, software, communications protocols, and management tools designed to deliver carrier and enterprise class wireless broadband access and other services primarily in the unlicensed RF spectrum. It provides technology platforms, such as airMAX platform, which includes proprietary protocols that contain technologies for minimizing signal noise; EdgeMAX, a disruptive price-performance software and systems routing platform; and airFiber, a point-to-point radio system. The company also offers UniFi Enterprise Wi-Fi System that includes Wi-Fi certified hardware with a software based management controller; UniFi Video H.264 megapixel IP cameras; and UniFi Video management software controller to manage multiple UniFi Video H.264 IP cameras and digital video recorder devices. In addition, it provides UniFi VOIP Phone, an enterprise desktop smartphone designed to integrate into the UniFi Enterprise System; UniFi Switches to deliver performance, switching, and PoE+ support for enterprise networks; and mFi, which includes hardware sensors, power devices, and management software that allows devices to be monitored and controlled remotely through Wi-Fi. Further, the company provides embedded radio products; and mounting brackets, cables, and power over Ethernet adapters. The company was formerly known as Pera Networks, Inc. and changed its name to Ubiquiti Networks, Inc. in 2005. Ubiquiti Networks, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Advisors’ Opinion:

  • [By Steve Symington]

    Shares of Ubiquiti Networks (NASDAQ:UBNT) climbed 33.4% in February, according to data fromS&P Global Market Intelligence, after the networking hardware company released better-than-expected quarterly results.

  • [By Leo Sun]

    One of those rivals was Ubiquiti Networks (NASDAQ:UBNT), a networking equipment company that sells long-distance Wi-Fi products for service providers and enterprise customers. In 2016, Ubiquiti followed Eero into the mesh home router network with itsAmpliFi wireless system,which includes a sleek box linked to mesh point antennas plugged into wall sockets.

  • [By Nicholas Rossolillo]

    Ubiquiti Networks (NASDAQ:UBNT) recently reported fiscal 2019 second-quarter results, and shares have been soaring ever since. Over the past three years, the stock has risen by more than 300%.

Top 10 Clean Energy Stocks To Watch Right Now

It’s important for investors to know how to invest in penny stocks safely. That’s because they’re often volatile and can sometimes be fraudulent, despite offering triple-digit returns in a matter of weeks. We’ll show you our top two strategies for finding good penny stocks to buy, plus our small-cap stock pick primed for double-digit growth this year…

Video3 Strategies for Investing in Penny Stocks

If you’re looking for proof of just how explosively profitable penny stocks are, Delcath Systems Inc. (Nasdaq: DCTH) is a perfect piece of evidence. This company saw its stock price surge from $0.02 on June 1 to $0.19 on June 26. That marked a stunning 850% gain, which happened after the company announced phase 2 trial data for its cancer drug Melphalan would be released.

But these triple-digit returns aren’t always justified by the company’s profits or business potential. For instance, Chinese energy company Hongli Clean Energy Technologies Corp. (Nasdaq: CETC) saw shares jump 144% from $1.90 to $4.63 during just the first five sessions of April.

Top 10 Clean Energy Stocks To Watch Right Now: TherapeuticsMD, Inc.(TXMD)

Advisors’ Opinion:

  • [By ]

    TherapeuticsMD (Nasdaq: TXMD) is a pharmaceutical company with an exclusive focus on products for women and advanced hormone therapies. Biotech stocks are often a target for short sellers because of the uncertainty around drug development and approvals.

  • [By Max Byerly]

    TherapeuticsMD Inc (NASDAQ:TXMD) – Investment analysts at Oppenheimer increased their Q3 2018 EPS estimates for shares of TherapeuticsMD in a research report issued to clients and investors on Tuesday, June 5th. Oppenheimer analyst J. Olson now anticipates that the company will post earnings per share of ($0.08) for the quarter, up from their previous estimate of ($0.09). Oppenheimer currently has a “Buy” rating and a $12.00 price target on the stock. Oppenheimer also issued estimates for TherapeuticsMD’s Q4 2018 earnings at ($0.03) EPS, FY2018 earnings at ($0.32) EPS, FY2019 earnings at ($0.10) EPS, FY2020 earnings at $0.22 EPS, FY2021 earnings at $0.44 EPS and FY2022 earnings at $0.70 EPS.

  • [By Joseph Griffin]

    JPMorgan Chase & Co. initiated coverage on shares of TherapeuticsMD (NASDAQ:TXMD) in a report issued on Friday, MarketBeat Ratings reports. The brokerage issued an overweight rating and a $11.00 price target on the stock.

  • [By Brian Feroldi]

    After receiving some analyst love, shares of TherapeuticsMD (NASDAQ:TXMD), a commercial-stage biopharma focused on women’s health, rose 13% as of 3:35 p.m. EDT Tuesday.

  • [By Lisa Levin]

    Breaking news

    HP Inc (NYSE: HPQ) reported upbeat revenue for its second quarter and raised its profit outlook for the full year. The company named Steve Fieler as its CFO.
    TherapeuticsMD, Inc. (NASDAQ: TXMD) reported the FDA approval of TX-004HR: IMVEXXY (estradiol vaginal inserts) for moderate to severe dyspareunia due to menopause.
    salesforce.com, inc. (NYSE: CRM) reported better-than-expected earnings for its first quarter and raised its forecast for the full year.
    SpartanNash Co (NASDAQ: SPTN) reported upbeat earnings for its first quarter on Tuesday.

Top 10 Clean Energy Stocks To Watch Right Now: American Airlines Group, Inc.(AAL)

Advisors’ Opinion:

  • [By Chris Lange]

    American Airlines Group Inc. (NASDAQ: AAL) will share its latest quarterly earnings on Thursday. The consensus estimates call for $0.90 in EPS and $10.56 billion in revenue. Shares ended last week at $58.06, in a 52-week range of $39.21 to $59.08. The consensus analyst target is $63.44.

  • [By Joseph Griffin]

    Anglo American (LON:AAL)‘s stock had its “overweight” rating reaffirmed by equities research analysts at JPMorgan Chase & Co. in a research report issued to clients and investors on Wednesday.

  • [By Adam Levine-Weinberg]

    However, earlier this week, Hawaiian announced that it will suspend its Honolulu-Beijing route in October. That made it the second U.S. carrier — after American Airlines (NASDAQ:AAL) — to slash capacity to China this week.

  • [By Adam Levine-Weinberg]

    In recent years, American Airlines (NASDAQ:AAL) CEO Doug Parker has been one of the most adamant proponents of the thesis that consolidation has permanently transformed the U.S. airline industry, leading to a new era of prosperity for the sector.

Top 10 Clean Energy Stocks To Watch Right Now: Green Plains, Inc.(GPRE)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Green Plains (NASDAQ:GPRE) was downgraded by equities research analysts at ValuEngine from a “hold” rating to a “sell” rating in a report issued on Friday.

  • [By Joseph Griffin]

    These are some of the media headlines that may have impacted Accern Sentiment’s analysis:

    Get Green Plains alerts:

    At $20.45 Green Plains Inc. (GPRE) Forms Bearish Multiple Bottom Chart Pattern (thecasualsmart.com) Remarkable Runner — Green Plains Inc. (GPRE) (stockmarketstop.com) Today’s Hot Stock Under Review – Green Plains Inc. (NASDAQ:GPRE) (nasdaqjournal.com) Green Plains Inc. (GPRE): Stay Cool with Active Stock: (bitcoinpriceupdate.review) Latest Tally Of Analyst Opinions: Ambev SA (NYSE:ABEV), Green Plains Inc. (NASDAQ:GPRE), Washington Prime … (journalfinance.net)

    GPRE has been the subject of several recent research reports. Zacks Investment Research cut Green Plains from a “buy” rating to a “hold” rating in a report on Wednesday, May 2nd. ValuEngine raised Green Plains from a “sell” rating to a “hold” rating in a report on Wednesday, May 2nd. Finally, BidaskClub raised Green Plains from a “hold” rating to a “buy” rating in a research note on Friday, June 1st. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and five have given a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $25.17.

  • [By Motley Fool Transcription]

    Green Plains Inc. (NASDAQ:GPRE)Q4 2018 Earnings Conference CallFeb. 11, 2019, 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 Clean Energy Stocks To Watch Right Now: Petroleo Brasileiro S.A.- Petrobras(PBR)

Advisors’ Opinion:

  • [By Chris Lange]

    Short interest at Petroleo Brasileiro S.A. (NYSE: PBR), or Petrobras, increased to 47.03 million shares from the previous 43.13 million. The stock traded at $9.89 a share in a 52-week range of $7.61 to $17.20. Unfortunately, Petrobras may be trading on an entirely different set of fundamentals and sentiment due to its ongoing woes in Brazil.

  • [By Chris Lange]

    Short interest at Petroleo Brasileiro S.A. (NYSE: PBR), or Petrobras, rose to 27.58 million shares from the previous 27.11 million. The stock traded at $15.96 a share, in a 52-week range of $9.02 to $17.20. Unfortunately, Petrobras may be trading on an entirely different set of fundamentals and sentiment due to its ongoing woes in Brazil.

  • [By Jon C. Ogg]

    Petroleo Brasileiro S.A. (NYSE: PBR), or Petrobras, was downgraded to Equal Weight from Overweight at Morgan Stanley, and Credit Suisse downgraded it to Neutral from Outperform. The American depositary shares closed down 3.76% at $15.11 on Wednesday and were indicated down 10% at $13.46 after the Brazilian oil giant slashed diesel prices to ease trucker strike in Brazil.

Top 10 Clean Energy Stocks To Watch Right Now: Summit Midstream Partners, LP(SMLP)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Meanwhile, ExxonMobil’s XTO subsidiary agreed to dedicate natural gas produced from two counties in New Mexico to Summit Midstream Partners (NYSE:SMLP) last July. Summit is currently investing $110 million in building out a natural gas gathering and processing system to serve new wells in that area, which should be in service this month. In addition, Summit has proposed a long-haul pipeline to move gas out of the region, which would cost up to $450 million and could help support Exxon’s growing gas output from the area.

  • [By Max Byerly]

    Summit Midstream Partners (NYSE:SMLP) released its quarterly earnings data on Thursday. The pipeline company reported ($0.18) EPS for the quarter, missing the consensus estimate of $0.12 by ($0.30), MarketWatch Earnings reports. Summit Midstream Partners had a return on equity of 12.62% and a net margin of 17.59%. The business had revenue of $117.32 million during the quarter, compared to the consensus estimate of $106.68 million.

  • [By Matthew DiLallo]

    Exxon is also working with Summit Midstream Partners (NYSE:SMLP) on the development of the Double E pipeline, which is a regional gas pipeline in the Permian. Exxon not only signed up to be a major shipper on Double E but has the option to acquire a 50% interest in the project. That equity stake means Exxon could help fund as much as half of the construction costs, which would ease the financial burden on the cash-strapped Summit Midstream. While Summit Midstream has yet to sanction the project, the company believes it will soon have enough shippers to move forward, which puts it on track to have the pipeline in service by the second quarter of 2021.

  • [By Matthew DiLallo]

    Meanwhile, Exxon signed on to be a foundation shipper on Summit Midstream’s (NYSE:SMLP) Double E Pipeline by committing to a firm transportation agreement for up to half of the pipeline’s capacity. Further, Exxon has the right to acquire up to a 50% interest in the pipeline from Summit, which could help with securing project-related funding. By getting Exxon’s backing, Summit is increasingly likely to move forward with this pipeline.

Top 10 Clean Energy Stocks To Watch Right Now: Buffalo Wild Wings Inc.(BWLD)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Dave & Busters Entertainment tripling in value before falling back while small cap upscale gentlemen’s clubs and restaurant owner RCI Hospitality Holdings, Inc (NASDAQ: RICK) began taking off in 2016 and small cap Buffalo Wild Wings (NASDAQ: BWLD) is being acquired by Arby’s Restaurant Group:

  • [By Steve Symington]

    That’s not to say it was a quiet day for every stock on the market. With earnings season ramping up, brewing giant Anheuser-Busch InBev (NYSE:BUD) and restaurant chain Buffalo Wild Wings (NASDAQ:BWLD) served as an exercise in contrast as investors reacted to their respective quarterly reports.

Top 10 Clean Energy Stocks To Watch Right Now: Officemax Incorporated(OMX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Shivom (CURRENCY:OMX) traded down 12.7% against the U.S. dollar during the 24-hour period ending at 13:00 PM E.T. on September 26th. Shivom has a market cap of $3.56 million and approximately $42,709.00 worth of Shivom was traded on exchanges in the last day. In the last seven days, Shivom has traded down 8.3% against the U.S. dollar. One Shivom token can now be purchased for $0.0062 or 0.00000095 BTC on popular cryptocurrency exchanges including CoinBene, Kucoin, Coinsuper and IDEX.

  • [By Logan Wallace]

    Shivom (CURRENCY:OMX) traded 3.2% higher against the US dollar during the 24-hour period ending at 23:00 PM E.T. on September 13th. One Shivom token can currently be purchased for about $0.0069 or 0.00000105 BTC on popular exchanges including Kucoin, CoinBene, Coinsuper and DDEX. During the last week, Shivom has traded 3.3% lower against the US dollar. Shivom has a total market capitalization of $3.93 million and $74,531.00 worth of Shivom was traded on exchanges in the last day.

Top 10 Clean Energy Stocks To Watch Right Now: eHealth Inc.(EHTH)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8.
    Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica.
    DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.
    eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results.
    Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results.
    SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results.
    Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results.
    Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36.
    Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday.
    ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial.
    Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70.
    Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday.
    Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M
  • [By Lisa Levin]

    Shares of eHealth, Inc. (NASDAQ: EHTH) got a boost, shooting up 16 percent to $18.64 as the company posted upbeat Q1 results.

    Enova International, Inc. (NYSE: ENVA) shares were also up, gaining 25 percent to $28.35 following Q1 results.

  • [By Motley Fool Transcribers]

    EHealth Inc  (NASDAQ:EHTH)Q4 2018 Earnings Conference CallFeb. 21, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    Los Angeles Capital Management & Equity Research Inc. boosted its stake in eHealth, Inc. (NASDAQ:EHTH) by 61.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 22,655 shares of the financial services provider’s stock after acquiring an additional 8,630 shares during the period. Los Angeles Capital Management & Equity Research Inc. owned about 0.12% of eHealth worth $501,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    eHealth (NASDAQ:EHTH) had its price objective raised by SunTrust Banks to $75.00 in a research report sent to investors on Friday morning, The Fly reports. They currently have a buy rating on the financial services provider’s stock.

  • [By Joseph Griffin]

    ValuEngine lowered shares of eHealth (NASDAQ:EHTH) from a buy rating to a hold rating in a research report report published on Tuesday.

    EHTH has been the topic of several other reports. Cantor Fitzgerald boosted their price target on shares of eHealth to $22.00 and gave the stock an overweight rating in a report on Friday, May 18th. Chardan Capital initiated coverage on shares of eHealth in a report on Thursday, August 16th. They set a buy rating and a $40.00 price target on the stock. BidaskClub upgraded shares of eHealth from a buy rating to a strong-buy rating in a report on Thursday, August 16th. Finally, Zacks Investment Research cut shares of eHealth from a hold rating to a sell rating in a report on Wednesday, August 1st. Four equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of Buy and a consensus target price of $26.86.

Top 10 Clean Energy Stocks To Watch Right Now: Jabil Circuit Inc.(JBL)

Advisors’ Opinion:

  • [By Dan Caplinger]

    The stock market had an up-and-down day on Tuesday, with early gains giving way to small losses for most major benchmarks by the end of the session. Despite the modest declines, indexes remain near record highs, and even the ongoing back-and-forth of trade-related comments — both conciliatory and threatening — hasn’t done anything more than put a minor dent in a major advance for stocks in the third quarter. Yet some companies suffered from bad news. CenturyLink (NYSE:CTL), Jabil (NYSE:JBL), and Neogen (NASDAQ:NEOG) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Shane Hupp]

    Robeco Institutional Asset Management B.V. cut its holdings in shares of Jabil Inc (NYSE:JBL) by 13.4% in the 4th quarter, Holdings Channel reports. The firm owned 161,796 shares of the technology company’s stock after selling 24,970 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Jabil were worth $3,999,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Max Byerly]

    Jabil (NYSE:JBL) was downgraded by research analysts at TheStreet from a “b-” rating to a “c+” rating in a research note issued to investors on Tuesday.

  • [By Logan Wallace]

    Millennium Management LLC increased its stake in shares of Jabil Inc (NYSE:JBL) by 182.3% during the second quarter, HoldingsChannel.com reports. The fund owned 262,830 shares of the technology company’s stock after acquiring an additional 169,736 shares during the quarter. Millennium Management LLC’s holdings in Jabil were worth $7,270,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Rich Duprey]

    And the licensing deal with Jabil (NYSE: JBL), which makes GoPro cameras, to have the camera tech added into third-party devices, expands the window of opportunity further.

Top 10 Clean Energy Stocks To Watch Right Now: Nustar Energy L.P.(NS)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of BIGLARI CAPITAL CORP.’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=BIGLARI+CAPITAL+CORP.

    These are the top 5 holdings of BIGLARI CAPITAL CORP.Cracker Barrel Old Country Store Inc (CBRL) – 4,737,794 shares, 97.61% of the total portfolio. Valeant Pharmaceuticals International Inc (VRX) – 395,000 shares, 0.81% of the total portfolio. Investors Title Co (ITIC) – 30,000 shares, 0.78% of the total portfolio. Unico American Corp (UNAM) – 527,100 shares, 0.54% of the total portfolio. NuStar Energy LP (NS) – 68,500 shares, 0.18% of the total portfolio. New PositionNew

  • [By Ethan Ryder]

    NuStar Energy (NYSE:NS) had its price target upped by Barclays from $23.00 to $25.00 in a research report report published on Wednesday morning. They currently have an equal weight rating on the pipeline company’s stock.

  • [By Max Byerly]

    NuStar Energy L.P. (NYSE:NS) declared a quarterly dividend on Friday, April 27th, Wall Street Journal reports. Stockholders of record on Tuesday, May 8th will be paid a dividend of 0.60 per share by the pipeline company on Monday, May 14th. This represents a $2.40 annualized dividend and a dividend yield of 11.49%. The ex-dividend date is Monday, May 7th.

  • [By Stephan Byrd]

    HRT Financial LLC bought a new stake in shares of NuStar Energy L.P. (NYSE:NS) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 12,350 shares of the pipeline company’s stock, valued at approximately $279,000.

  • [By Shane Hupp]

    Shares of NuStar Energy L.P. (NYSE:NS) have received an average rating of “Hold” from the twelve research firms that are currently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, nine have issued a hold recommendation and one has issued a buy recommendation on the company. The average 1 year price target among analysts that have covered the stock in the last year is $26.25.

Top 10 Heal Care Stocks To Buy Right Now

Deutsche Bank set a €5.30 ($6.16) target price on Enel (BIT:ENEL) in a research report sent to investors on Thursday morning. The brokerage currently has a neutral rating on the stock.

ENEL has been the subject of a number of other research reports. Societe Generale set a €6.00 ($6.98) target price on shares of Enel and gave the stock a buy rating in a research report on Wednesday, May 23rd. Deutsche Bank set a €5.40 ($6.28) target price on shares of Enel and gave the stock a neutral rating in a research report on Thursday, May 31st. Goldman Sachs Group set a €6.15 ($7.15) target price on shares of Enel and gave the stock a buy rating in a research report on Wednesday, May 2nd. Morgan Stanley set a €6.00 ($6.98) target price on shares of Enel and gave the stock a buy rating in a research report on Tuesday, May 29th. Finally, Royal Bank of Canada set a €5.75 ($6.69) target price on shares of Enel and gave the stock a buy rating in a research report on Thursday, May 31st. Five investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. The company currently has a consensus rating of Buy and an average target price of €5.76 ($6.69).

Top 10 Heal Care Stocks To Buy Right Now: Seadrill Limited(SDRL)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Shares of Seadrill (NYSE:SDRL) rocketed in May, ending the month up 78%. Fueling the offshore driller’s rebound were fading investor fears after the company received approval for its plan to exit bankruptcy in April.

  • [By Lisa Levin]

    Thursday morning, the energy shares rose 0.76 percent. Meanwhile, top gainers in the sector included Seadrill Limited (NYSE: SDRL), up 59 percent, and EP Energy Corporation (NYSE: EPE) up 7 percent.

  • [By Lisa Levin]

    Thursday afternoon, the energy shares rose 1.16 percent. Meanwhile, top gainers in the sector included Seadrill Limited (NYSE: SDRL), up 33 percent, and Ultra Petroleum Corp. (NYSE: UPL) up 14 percent.

  • [By Lisa Levin]

    On Wednesday, the energy shares climbed 1.48 percent. Meanwhile, top gainers in the sector included SeaDrill Limited (NYSE: SDRL), up 15 percent, and EP Energy Corporation (NYSE: EPE), up 15 percent.

  • [By Money Morning News Team]

    (Nasdaq: CNET)

    $2.95 34.76%
    Seadrill Ltd. (NYSE: SDRL) $0.28 33.81%
    Intelsat Corp. (NYSE: I) $9.11 31.50%
    Navios Maritime Midstream Partners LP (NYE: NAP) $4.42 29.18%
    Limelight Networks Inc. (Nasdaq: LLNW) $4.89 28.61%
    Enphase Energy Inc. (Nasdaq: ENPH) $5.05 24.62%

    As you can see in the table above, penny stocks have the potential to provide tremendous returns for enterprising investors. However, it’s important to note that investing in penny stocks is also incredibly risky.

  • [By Lisa Levin]

    Wednesday morning, the energy shares climbed 1.29 percent. Meanwhile, top gainers in the sector included SeaDrill Limited (NYSE: SDRL), up 19 percent, and Energy XXI Gulf Coast, Inc. (NASDAQ: EGC), up 10 percent.

Top 10 Heal Care Stocks To Buy Right Now: AMTEK, Inc.(AME)

Advisors’ Opinion:

  • [By Logan Wallace]

    These are some of the news articles that may have impacted Accern Sentiment’s scoring:

    Get AMETEK alerts:

    Ac Power Source Supply Market 2018 Global Share- AMETEK Programmable Power, Pacific Power Source and … (theexpertconsulting.com) The Whispers about AMETEK, Inc. (AME) and Omeros Corporation (OMER) (nmsunews.com) Global Neutron Generators Market Analysis 2018 Del Mar Photonics, VNIIA, AMETEK ORTEC, Adelphi Technology … (theexpertconsulting.com) AMETEK, Inc. (AME): Most Popular stock: (stockquote.review) Ametek granted partial judgment in alleged ground contamination cased filed by mobile home parks’ owners (norcalrecord.com)

    Several research firms have recently commented on AME. Morgan Stanley lifted their price target on shares of AMETEK from $76.00 to $79.00 and gave the company an “equal weight” rating in a research report on Thursday, May 3rd. BMO Capital Markets lifted their price target on shares of AMETEK from $90.00 to $92.00 and gave the company an “outperform” rating in a research report on Thursday, May 3rd. Zacks Investment Research lowered shares of AMETEK from a “buy” rating to a “hold” rating in a research report on Thursday, April 12th. DA Davidson began coverage on shares of AMETEK in a research report on Thursday, April 12th. They set a “buy” rating and a $85.00 price target on the stock. Finally, ValuEngine raised shares of AMETEK from a “hold” rating to a “buy” rating in a research report on Thursday, March 1st. Three investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $82.00.

  • [By Ethan Ryder]

    UBS Group AG boosted its holdings in AMETEK, Inc. (NYSE:AME) by 97.1% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 260,024 shares of the technology company’s stock after acquiring an additional 128,083 shares during the period. UBS Group AG owned about 0.11% of AMETEK worth $19,754,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    Mountain Pacific Investment Advisers Inc. ID trimmed its stake in shares of AMETEK, Inc. (NYSE:AME) by 1.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 533,274 shares of the technology company’s stock after selling 5,917 shares during the quarter. AMETEK accounts for 4.2% of Mountain Pacific Investment Advisers Inc. ID’s portfolio, making the stock its 3rd largest holding. Mountain Pacific Investment Advisers Inc. ID’s holdings in AMETEK were worth $40,513,000 as of its most recent SEC filing.

  • [By Motley Fool Transcribing]

    Ametek (NYSE:AME) Q4 2018 Earnings Conference CallFeb. 5, 2019 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    Rhumbline Advisers grew its holdings in shares of AMETEK, Inc. (NYSE:AME) by 3.0% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 450,212 shares of the technology company’s stock after purchasing an additional 13,189 shares during the quarter. Rhumbline Advisers’ holdings in AMETEK were worth $32,487,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    AMETEK (NYSE:AME) had its target price upped by BMO Capital Markets from $92.00 to $93.00 in a report issued on Wednesday morning. BMO Capital Markets currently has an outperform rating on the technology company’s stock.

Top 10 Heal Care Stocks To Buy Right Now: Fisher(j)

Advisors’ Opinion:

  • [By Shane Hupp]

    Joincoin (CURRENCY:J) traded 17.5% lower against the U.S. dollar during the twenty-four hour period ending at 17:00 PM ET on June 2nd. Over the last seven days, Joincoin has traded down 4.4% against the U.S. dollar. One Joincoin coin can now be purchased for $0.0862 or 0.00001129 BTC on major exchanges. Joincoin has a market capitalization of $267,889.00 and approximately $123.00 worth of Joincoin was traded on exchanges in the last 24 hours.

  • [By Joseph Griffin]

    Joincoin (CURRENCY:J) traded 1.7% lower against the U.S. dollar during the 24 hour period ending at 0:00 AM ET on May 8th. Joincoin has a total market cap of $145,714.00 and $7.00 worth of Joincoin was traded on exchanges in the last 24 hours. During the last week, Joincoin has traded up 28.6% against the U.S. dollar. One Joincoin coin can currently be bought for about $0.0471 or 0.00000521 BTC on cryptocurrency exchanges.

  • [By Logan Wallace]

    Joincoin (CURRENCY:J) traded 12.5% higher against the dollar during the 24-hour period ending at 10:00 AM ET on September 30th. Joincoin has a market cap of $98,508.00 and $17.00 worth of Joincoin was traded on exchanges in the last day. One Joincoin coin can now be bought for $0.0309 or 0.00000467 BTC on popular exchanges. During the last seven days, Joincoin has traded 8.2% lower against the dollar.

  • [By Shane Hupp]

    Joincoin (J) is a proof-of-work (PoW) coin that uses the Multiple hashing algorithm. Its launch date was August 13th, 2014. Joincoin’s total supply is 3,173,702 coins. Joincoin’s official website is bitcointalk.org/index.php?topic=737405.0. Joincoin’s official Twitter account is @Joincoin_Team.

  • [By Logan Wallace]

    Joincoin (CURRENCY:J) traded 22.3% higher against the dollar during the 1 day period ending at 9:00 AM E.T. on October 2nd. Joincoin has a total market capitalization of $95,205.00 and $22.00 worth of Joincoin was traded on exchanges in the last 24 hours. During the last seven days, Joincoin has traded 6.1% lower against the dollar. One Joincoin coin can now be bought for approximately $0.0299 or 0.00000456 BTC on major cryptocurrency exchanges.

Top 10 Heal Care Stocks To Buy Right Now: AmerisourceBergen Corporation (Holding Co)(ABC)

Advisors’ Opinion:

  • [By Logan Wallace]

    AmerisourceBergen (NYSE: ABC) and Trxade Group (OTCMKTS:TRXD) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, dividends, earnings, institutional ownership and profitability.

  • [By Logan Wallace]

    These are some of the news stories that may have impacted Accern Sentiment Analysis’s analysis:

    Get AmerisourceBergen alerts:

    Stocks that Will Always Try to Do the Right Things: AmerisourceBergen Corporation (ABC), Republic Services, Inc. (RSG) (nmsunews.com) Fortune’s 5 most influential pharmaceutical distributors and PBMs (beckershospitalreview.com) Analyzing CVS Health and Walgreens’ Acquisitions (finance.yahoo.com) US Bioservices Collaborates with MedImpact Direct to Support Hemophilia Patients (businesswire.com) Add Bucks County to list of those suing opioid manufacturers, distributors (finance.yahoo.com)

    NYSE ABC opened at $82.14 on Friday. AmerisourceBergen has a fifty-two week low of $71.90 and a fifty-two week high of $106.27. The company has a debt-to-equity ratio of 1.38, a quick ratio of 0.48 and a current ratio of 0.94. The stock has a market cap of $18.15 billion, a price-to-earnings ratio of 13.97, a P/E/G ratio of 1.25 and a beta of 1.04.

  • [By Lee Jackson]

    Recently the managers removed AmerisourceBergen Corp (NYSE: ABC) and used the proceeds from the sale to increase the position they already held in Unitedhealth Group Inc. (NYSE: UNH).

  • [By Shane Hupp]

    AmerisourceBergen Corp. (NYSE:ABC) insider Robert P. Mauch sold 1,000 shares of the business’s stock in a transaction that occurred on Wednesday, June 13th. The shares were sold at an average price of $90.00, for a total value of $90,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

  • [By Shane Hupp]

    Dupont Capital Management Corp lessened its stake in shares of AmerisourceBergen (NYSE:ABC) by 92.7% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,327 shares of the company’s stock after selling 16,975 shares during the quarter. Dupont Capital Management Corp’s holdings in AmerisourceBergen were worth $114,000 as of its most recent filing with the Securities and Exchange Commission.

Top 10 Heal Care Stocks To Buy Right Now: Open Text Corporation(OTEX)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Open Text (OTEX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Open Text (OTEX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Open Text Corp (TSE:OTEX) (NASDAQ:OTEX)’s share price hit a new 52-week high during trading on Monday . The stock traded as high as C$46.80 and last traded at C$46.53, with a volume of 121029 shares changing hands. The stock had previously closed at C$46.16.

Top 10 Heal Care Stocks To Buy Right Now: Daiichi Sankyo Company, Limited (DSKYF)

Advisors’ Opinion:

  • [By ]

    Daiichi Sankyo (OTCPK:DSKYF)

    There are 4 members of the EGF receptor family, but in cancer research we tend to focus mainly on the first two: EGFR and HER2. But we are also gaining a better understanding of the third family member, HER3, which is an odd duck because of its willingness to form dimers not with itself, but with other members of the EGFR family. And it is highly active in PI3K/Akt signaling, as well. So it’s no surprise that companies are trying to exploit this receptor as a therapeutic target. DSKYF’s U3-1402 is an antibody-drug conjugate targeting HER3 and delivering a lethal payload to tumor cells. This phase 1/2 study focused on the use of this agent in metastatic breast cancer overexpressing HER3.

Top 10 Heal Care Stocks To Buy Right Now: Fitbit, Inc.(FIT)

Advisors’ Opinion:

  • [By Chris Lange]

    Fitbit Inc. (NYSE: FIT) also is set to release its most recent quarterly results on Monday. The consensus forecast calls for a net loss of $0.01 per share and $589.1 million in revenue. Shares closed on Friday at $5.28. The consensus price target is $6.64, and the 52-week range is $4.90 to $7.32.

  • [By Stephan Byrd]

    Shares of Fitbit Inc (NYSE:FIT) gapped up prior to trading on Tuesday . The stock had previously closed at $6.11, but opened at $5.89. Fitbit shares last traded at $6.26, with a volume of 494885 shares traded.

  • [By Leo Sun]

    Facebook acquired the Moves fitness app in 2014. It seemed like a smart purchase at the time, since surging demand for Fitbit (NYSE:FIT) devices had sparked a land grab in the wearables market. Move tracked a user’s location, recorded different movements (like walking, running, and cycling) between locations, and logged the number of steps taken. The app had scored about 40 million downloads at the time of Facebook’s buyout.

  • [By Rich Duprey]

    Fitbit (NYSE:FIT) has shipped some 1 million Versa smartwatches in a little over a month’s time. That indicates it not only got its product right this time, but that it is finally also a worthy competitor to Apple (NASDAQ:AAPL).

  • [By Evan Niu, CFA]

    Apple (NASDAQ:AAPL) and Fitbit (NYSE:FIT) have emerged as the two clear market leaders in smartwatches, with Apple Watch leading the way but Fitbit’s growing portfolio of smartwatches helping it secure the No. 2 spot while simultaneously driving a turnaround for the smaller company. Meanwhile, Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) subsidiary Google has ceded share, although the search giant is expected to jump in directly with a first-party Pixel Watch in the near future. Rumors of the company’s foray into the market were only fueled by recent news that Google acquired smartwatch tech from Fossil and is hiring for wearables design and engineering execs.

  • [By Motley Fool Staff]

    Gardner: Alright, company No. 5. Looking back over our first four, they’ve all been pretty good stock picks of ours, companies that a lot of Fools own and have done well with. This is one of my very worst picks, I’m sorry to say. Maybe a little bit of a hint, because it’s probably not that good a number or big a number these days. Matt, do you ever want a Fitbit (NYSE:FIT)?

Top 10 Heal Care Stocks To Buy Right Now: TherapeuticsMD, Inc.(TXMD)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Shares of TherapeuticsMD (NASDAQ:TXMD) rose more than 24% last month, according to data provided by S&P Global Market Intelligence. On the final day of July, the company announced the acquisition of a novel birth control product, Annovera, which then received U.S. Food and Drug Administration marketing approval in August.

  • [By Ethan Ryder]

    TherapeuticsMD Inc (NASDAQ:TXMD)’s share price was up 6.4% on Friday . The stock traded as high as $6.07 and last traded at $6.02. Approximately 2,747,655 shares were traded during mid-day trading, an increase of 38% from the average daily volume of 1,984,159 shares. The stock had previously closed at $5.66.

  • [By Brian Feroldi]

    After receiving some analyst love, shares of TherapeuticsMD (NASDAQ:TXMD), a commercial-stage biopharma focused on women’s health, rose 13% as of 3:35 p.m. EDT Tuesday.

  • [By Keith Speights]

    Axovant Sciences (NASDAQ:AXON), Deciphera Pharmaceuticals (NASDAQ:DCPH), and TherapeuticsMD (NASDAQ:TXMD) stocks soared by 26% or more this week. What sent these drug stocks into orbit? And are they still buys? Here’s the scoop behind the big gains and what could be next for the companies.

  • [By Cory Renauer]

    Shares of TherapeuticsMD (NASDAQ:TXMD), a biopharmaceutical company focused on women’s health, jumped 37.8% higher in January, according to data from S&P Global Market Intelligence. Investors were glad to hear the company’s new estradiol treatment for dyspareunia due to menopause is off to a better start than originally expected.

  • [By Joseph Griffin]

    JPMorgan Chase & Co. initiated coverage on shares of TherapeuticsMD (NASDAQ:TXMD) in a report issued on Friday, MarketBeat Ratings reports. The brokerage issued an overweight rating and a $11.00 price target on the stock.

Top 10 Heal Care Stocks To Buy Right Now: Golar LNG Partners LP(GMLP)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Shares of oil producers Laredo Petroleum (NYSE:LPI) and SM Energy (NYSE:SM), as well as units of Golar LNG Partners LP (NASDAQ:GMLP), an MLP that owns liquified natural gas carriers and floating storage and regasification units, all declined by double digits by Friday afternoon. Lower oil prices weighed on the first two, while an analyst downgrade was the culprit in the latter.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Golar LNG Partners (GMLP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Staff]

    Golar LNG Partners Partnership (NASDAQ:GMLP) Q1 2018 Earnings Conference CallMay. 31, 2018 11:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Matthew DiLallo]

    Shares of Golar LNG Limited (NASDAQ:GLNG) are plunging today, down more than 17% as of 10:45 a.m. EDT, after the company reported lackluster first-quarter results. The company’s master limited partnership, Golar LNG Partners (NASDAQ:GMLP), also dropped, falling nearly 10% by midmorning.

  • [By Stephan Byrd]

    Media stories about Golar LNG Partners (NASDAQ:GMLP) have trended somewhat positive on Monday, according to Accern Sentiment. The research firm rates the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Golar LNG Partners earned a media sentiment score of 0.23 on Accern’s scale. Accern also assigned media stories about the shipping company an impact score of 46.501475004652 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Top 10 Heal Care Stocks To Buy Right Now: DCT Industrial Trust Inc(DCT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Teza Capital Management LLC bought a new stake in DCT Industrial Trust Inc (NYSE:DCT) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 6,379 shares of the real estate investment trust’s stock, valued at approximately $359,000.

  • [By Joseph Griffin]

    Shares of DCT Industrial Trust Inc (NYSE:DCT) have been given an average recommendation of “Hold” by the ten ratings firms that are presently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, eight have given a hold rating and one has assigned a buy rating to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $62.83.

  • [By Logan Wallace]

    DECENT (CURRENCY:DCT) traded down 20.5% against the U.S. dollar during the 1-day period ending at 23:00 PM ET on September 5th. Over the last seven days, DECENT has traded 14% lower against the U.S. dollar. DECENT has a total market cap of $8.35 million and approximately $216,900.00 worth of DECENT was traded on exchanges in the last day. One DECENT coin can now be purchased for $0.16 or 0.00002516 BTC on major exchanges including Bittrex, Upbit, BCEX and HitBTC.

  • [By ]

    For an “Executive Decision” segment, Cramer spoke with Hamid Moghadam, chairman and CEO of the logistics REIT, Prologis Inc.  (PLD) , which recently announced the acquisition of DCT Industrial Trust (DCT) .

Top 10 Undervalued Stocks To Own For 2019

Small-cap stocks can deliver explosive gains — or sizable losses. Choose well, and these high-risk yet potentially high-reward stocks can deliver multibagger returns and turbocharge your portfolio’s overall performance. But choose poorly, and a small-cap stock can produce painful losses, up to and including a complete loss of capital should the business be forced into bankruptcy.

That’s why it’s so important to invest in only the strongest of these companies — those that possess the best business models and enjoy the largest growth opportunities. In this regard, here’s one of the most intriguing small-cap stocks available in the market today.

This small-cap stock can grow into something much larger in the years ahead. Image source: Getty Images.

In the mold of a young Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B), Boston Omaha (NASDAQ:BOMN) is a small conglomerate designed to generate attractive long-term returns through the consistent acquisition of undervalued assets. Its current businesses include insurance, real estate, and advertising, and the company plans to expand within these areas and others via both acquisitions and organic growth.

Top 10 Undervalued Stocks To Own For 2019: OncoMed Pharmaceuticals, Inc.(OMED)

Advisors’ Opinion:

  • [By Max Byerly]

    Here are some of the headlines that may have impacted Accern Sentiment Analysis’s rankings:

    Get Oncomed Pharmaceuticals alerts:

    Recent Technicals: OncoMed Pharmaceuticals (NASDAQ: OMED) (reagentsglobalmarket.com) OncoMed Pharmaceuticals, Inc. (NasdaqGS:OMED) Book to Market Valuation Stands at 0.479899 (vassarnews.com) Zacks: Analysts Expect Oncomed Pharmaceuticals Inc (OMED) Will Announce Quarterly Sales of $7.97 Million (americanbankingnews.com) Oncomed Pharmaceuticals Inc (OMED) Expected to Post Earnings of -$0.20 Per Share (americanbankingnews.com) Oncomed Pharmaceuticals Inc (OMED) Receives Average Rating of “Hold” from Analysts (americanbankingnews.com)

    Several brokerages have weighed in on OMED. Zacks Investment Research cut shares of Oncomed Pharmaceuticals from a “buy” rating to a “hold” rating in a research note on Tuesday, August 21st. ValuEngine raised shares of Oncomed Pharmaceuticals from a “strong sell” rating to a “sell” rating in a research note on Wednesday, May 2nd. Five research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $4.30.

Top 10 Undervalued Stocks To Own For 2019: American Superconductor Corporation(AMSC)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media coverage about American Superconductor (NASDAQ:AMSC) has been trending somewhat positive recently, according to Accern Sentiment. The research group identifies negative and positive media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. American Superconductor earned a media sentiment score of 0.16 on Accern’s scale. Accern also gave news headlines about the technology company an impact score of 47.29145037575 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

  • [By Max Byerly]

    News stories about American Superconductor (NASDAQ:AMSC) have been trending somewhat positive this week, Accern reports. Accern scores the sentiment of news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. American Superconductor earned a news impact score of 0.18 on Accern’s scale. Accern also gave media headlines about the technology company an impact score of 46.824635153043 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

  • [By Shane Hupp]

    News stories about American Superconductor (NASDAQ:AMSC) have been trending somewhat positive this week, Accern Sentiment reports. Accern identifies negative and positive media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. American Superconductor earned a coverage optimism score of 0.10 on Accern’s scale. Accern also assigned headlines about the technology company an impact score of 47.5442417425226 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on American Superconductor (AMSC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    American Superconductor (NASDAQ:AMSC) had its price target upped by investment analysts at B. Riley from $6.00 to $7.00 in a research note issued on Monday. The firm presently has a “neutral” rating on the technology company’s stock. B. Riley’s price objective suggests a potential upside of 10.06% from the company’s current price.

  • [By Shane Hupp]

    American Superconductor (NASDAQ:AMSC) last issued its earnings results on Tuesday, February 5th. The technology company reported ($0.11) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.18. The company had revenue of $14.13 million during the quarter, compared to the consensus estimate of $15.13 million. American Superconductor had a net margin of 52.83% and a negative return on equity of 29.09%. As a group, analysts anticipate that American Superconductor Co. will post -1.06 earnings per share for the current fiscal year.

Top 10 Undervalued Stocks To Own For 2019: Capital Senior Living Corporation(CSU)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Capital Senior Living (CSU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    State of New Jersey Common Pension Fund D lessened its stake in shares of Capital Senior Living (NYSE:CSU) by 5.3% in the first quarter, Holdings Channel reports. The institutional investor owned 180,000 shares of the company’s stock after selling 10,000 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in Capital Senior Living were worth $1,935,000 as of its most recent filing with the SEC.

  • [By Shane Hupp]

    $900.00 upgraded shares of Constellation Software (TSE:CSU) from a neutral rating to an outperform rating in a report issued on Tuesday morning.

    Other equities analysts have also issued reports about the stock. National Bank Financial lifted their price target on shares of Constellation Software from C$850.00 to C$875.00 and gave the stock a sector perform rating in a report on Friday, April 27th. CIBC lifted their price target on shares of Constellation Software from C$865.00 to C$900.00 in a report on Friday, April 27th. lifted their price target on shares of Constellation Software to C$980.00 in a report on Thursday, April 26th. Finally, Scotiabank lifted their price target on shares of Constellation Software from C$880.00 to C$940.00 and gave the stock an outperform rating in a report on Tuesday, April 24th. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The stock has an average rating of Hold and a consensus price target of C$901.88.

  • [By Stephan Byrd]

    Media stories about Capital Senior Living (NYSE:CSU) have trended somewhat positive on Sunday, Accern Sentiment Analysis reports. The research firm rates the sentiment of press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Capital Senior Living earned a daily sentiment score of 0.01 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 46.062391046142 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Top 10 Undervalued Stocks To Own For 2019: Colony Bankcorp Inc.(CBAN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Media stories about Colony Bankcorp (NASDAQ:CBAN) have trended somewhat positive this week, according to Accern. The research group identifies positive and negative media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Colony Bankcorp earned a daily sentiment score of 0.02 on Accern’s scale. Accern also gave news stories about the financial services provider an impact score of 48.3992787299045 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

  • [By Logan Wallace]

    Headlines about Colony Bankcorp (NASDAQ:CBAN) have trended somewhat positive on Saturday, Accern Sentiment reports. The research group identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Colony Bankcorp earned a media sentiment score of 0.16 on Accern’s scale. Accern also assigned news stories about the financial services provider an impact score of 46.0420470648687 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Max Byerly]

    Media headlines about Colony Bankcorp (NASDAQ:CBAN) have been trending somewhat positive this week, Accern Sentiment Analysis reports. Accern scores the sentiment of media coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Colony Bankcorp earned a media sentiment score of 0.13 on Accern’s scale. Accern also gave news articles about the financial services provider an impact score of 46.5935973221915 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

Top 10 Undervalued Stocks To Own For 2019: Terex Corporation(TEX)

Advisors’ Opinion:

  • [By Rich Smith]

    All year long, Terex (NYSE:TEX) stock has been pacing the S&P 500’s performance — and even leading it a bit, up 15% to the market’s 14% gain. Today, shares are moving in and out of negative territory.

  • [By Lee Samaha]

    Shares in construction equipment company Terex Corporation (NYSE:TEX) fell 12.2% in August, according to data from S&P Global Market Intelligence. Since most of the fall occurred in the immediate aftermath of the second-quarter earnings report, which came out on the last day of July, it’s reasonable to conclude that investors didn’t like something about Terex’s presentation.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Terex (TEX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Terex (TEX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Asset Management One Co. Ltd. acquired a new stake in Terex Co. (NYSE:TEX) during the first quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 9,770 shares of the industrial products company’s stock, valued at approximately $365,000.

Top 10 Undervalued Stocks To Own For 2019: Knowles Corporation(KN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Knowles (KN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    These are some of the news articles that may have impacted Accern Sentiment’s scoring:

    Get Knowles alerts:

    Head to Head Contrast: Knowles (KN) vs. Sony (SNE) (americanbankingnews.com) Knowles (KN) Given Consensus Rating of “Hold” by Analysts (americanbankingnews.com) Four seniors nab scholarships from Siouxland Officials Association (siouxcityjournal.com) When is Who Dares Wins on BBC One tonight, how old is host Nick Knowles and how does the game show work? (thesun.co.uk) Local students learn the art of architecture (dailytidings.com)

    KN has been the subject of several research analyst reports. Craig Hallum restated a “buy” rating and set a $17.00 price target (down from $20.00) on shares of Knowles in a research report on Thursday, February 8th. Zacks Investment Research lowered Knowles from a “hold” rating to a “sell” rating in a research report on Wednesday, February 14th. ValuEngine lowered Knowles from a “hold” rating to a “sell” rating in a research report on Monday, April 2nd. JPMorgan Chase lowered their price target on Knowles from $16.00 to $13.50 and set a “neutral” rating for the company in a research report on Tuesday, April 24th. Finally, Lake Street Capital lowered their price target on Knowles from $19.00 to $17.00 and set a “buy” rating for the company in a research report on Thursday, February 8th. Three investment analysts have rated the stock with a sell rating, two have given a hold rating and four have issued a buy rating to the company. The company has an average rating of “Hold” and an average target price of $17.29.

  • [By Lisa Levin]

    Shares of Knowles Corporation (NYSE: KN) got a boost, shooting up 15 percent to $12.83 as the company reported Q1 results.

    SVB Financial Group (NASDAQ: SIVB) shares were also up, gaining 19 percent to $305.90 following strong quarterly results.

Top 10 Undervalued Stocks To Own For 2019: Vanguard Extended Market ETF (VXF)

Advisors’ Opinion:

  • [By Max Byerly]

    Regal Investment Advisors LLC grew its stake in shares of Vanguard Extended Market ETF (NYSEARCA:VXF) by 2.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 11,927 shares of the company’s stock after purchasing an additional 311 shares during the quarter. Regal Investment Advisors LLC’s holdings in Vanguard Extended Market ETF were worth $1,190,000 at the end of the most recent quarter.

  • [By Max Byerly]

    Vanguard Extended Market ETF (NYSEARCA:VXF) declared a quarterly dividend on Thursday, June 28th, Wall Street Journal reports. Investors of record on Friday, June 29th will be given a dividend of 0.3704 per share on Tuesday, July 3rd. This represents a $1.48 annualized dividend and a yield of 1.26%. The ex-dividend date is Thursday, June 28th. This is an increase from Vanguard Extended Market ETF’s previous quarterly dividend of $0.32.

  • [By Joseph Griffin]

    MML Investors Services LLC lowered its position in shares of Vanguard Extended Market ETF (NYSEARCA:VXF) by 14.5% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 11,370 shares of the company’s stock after selling 1,926 shares during the quarter. MML Investors Services LLC’s holdings in Vanguard Extended Market ETF were worth $1,268,000 as of its most recent filing with the SEC.

Top 10 Undervalued Stocks To Own For 2019: Euro FX(P)

Advisors’ Opinion:

  • [By Rick Munarriz]

    Pandora (NYSE:P) is hitting the “last dance” phase of its life as a stand-alone public company, and if anyone wants to outbid Sirius XM Radio (NASDAQ:SIRI) for the streaming music pioneer they better speak up soon. Sirius XM announced the all-stock deal initially valued at $3.5 billion on Monday. 

  • [By Timothy Green]

    Music-streaming company Pandora (NYSE:P) finally launched an on-demand subscription service in early 2017. Pandora Premium, priced at $9.99 per month, directly competes with Spotify and Apple Music. The company’s goal is to convert a significant chunk of its ad-supported listener base into subscribers. In addition to the new on-demand service, Pandora offers an ad-free version of its core internet radio experience for $4.99 per month.

  • [By Joseph Griffin]

    ValuEngine upgraded shares of Pandora Media (NYSE:P) from a hold rating to a buy rating in a report published on Tuesday.

    A number of other equities research analysts also recently weighed in on the company. Zacks Investment Research raised Pandora Media from a hold rating to a buy rating and set a $9.25 target price on the stock in a research report on Saturday, August 4th. Wedbush set a $10.00 target price on Pandora Media and gave the stock a buy rating in a research report on Wednesday, August 1st. Canaccord Genuity set a $10.00 target price on Pandora Media and gave the stock a buy rating in a research report on Wednesday, August 1st. Susquehanna Bancshares lifted their target price on Pandora Media from $7.00 to $8.00 and gave the stock a neutral rating in a research report on Wednesday, August 1st. Finally, BMO Capital Markets lifted their target price on Pandora Media from $12.00 to $13.00 and gave the stock an outperform rating in a research report on Wednesday, August 1st. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. The company has an average rating of Buy and a consensus price target of $7.85.

Top 10 Undervalued Stocks To Own For 2019: TherapeuticsMD, Inc.(TXMD)

Advisors’ Opinion:

  • [By Joseph Griffin]

    JPMorgan Chase & Co. initiated coverage on shares of TherapeuticsMD (NASDAQ:TXMD) in a report issued on Friday, MarketBeat Ratings reports. The brokerage issued an overweight rating and a $11.00 price target on the stock.

  • [By Max Byerly]

    TherapeuticsMD Inc (NASDAQ:TXMD) – Equities researchers at Cantor Fitzgerald reduced their FY2018 earnings estimates for shares of TherapeuticsMD in a research report issued on Tuesday, August 14th. Cantor Fitzgerald analyst W. Tanner now expects that the company will post earnings per share of ($0.68) for the year, down from their previous estimate of ($0.62). Cantor Fitzgerald currently has a “Overweight” rating and a $27.00 target price on the stock.

  • [By Shane Hupp]

    Oppenheimer set a $14.00 price objective on TherapeuticsMD (NASDAQ:TXMD) in a research report report published on Tuesday morning. The brokerage currently has a buy rating on the stock.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on TherapeuticsMD (TXMD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Brian Feroldi]

    After receiving some analyst love, shares of TherapeuticsMD (NASDAQ:TXMD), a commercial-stage biopharma focused on women’s health, rose 13% as of 3:35 p.m. EDT Tuesday.

  • [By Max Byerly]

    TherapeuticsMD Inc (NASDAQ:TXMD) – Investment analysts at Oppenheimer increased their Q3 2018 EPS estimates for shares of TherapeuticsMD in a research report issued to clients and investors on Tuesday, June 5th. Oppenheimer analyst J. Olson now anticipates that the company will post earnings per share of ($0.08) for the quarter, up from their previous estimate of ($0.09). Oppenheimer currently has a “Buy” rating and a $12.00 price target on the stock. Oppenheimer also issued estimates for TherapeuticsMD’s Q4 2018 earnings at ($0.03) EPS, FY2018 earnings at ($0.32) EPS, FY2019 earnings at ($0.10) EPS, FY2020 earnings at $0.22 EPS, FY2021 earnings at $0.44 EPS and FY2022 earnings at $0.70 EPS.

Top 10 Undervalued Stocks To Own For 2019: Galapagos NV(GLPG)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on GALAPAGOS NV/S (GLPG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Todd Campbell]

    Galapagos N.V. (NASDAQ:GLPG) is developing new triplet combination therapies with AbbVie (NYSE:ABBV) for cystic fibrosis that the two companies hope can challenge Vertex Pharmaceuticals (NASDAQ:VRTX) someday. Unfortunately, the results reported yesterday from a mid-stage study did not inspire confidence. Is Galapagos’ plan to tackle cystic fibrosis a failure? 

  • [By Keith Speights]

    Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) were trading 14% higher as of 11 a.m. EDT on Friday. The nice jump for the biotech stock came after Galapagos N.V. (NASDAQ:GLPG) announced disappointing results Thursday evening from a phase 2 clinical study evaluating C2 corrector GLPG2737 in treating cystic fibrosis (CF).

  • [By Max Byerly]

    Dorsey Wright & Associates lessened its stake in shares of GALAPAGOS NV/S (NASDAQ:GLPG) by 33.3% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 65,744 shares of the biotechnology company’s stock after selling 32,800 shares during the period. GALAPAGOS NV/S accounts for approximately 1.3% of Dorsey Wright & Associates’ holdings, making the stock its 17th biggest position. Dorsey Wright & Associates owned 0.13% of GALAPAGOS NV/S worth $7,391,000 at the end of the most recent reporting period.

  • [By Todd Campbell]

    Eager to participate in the multibillion-dollar market for autoimmune-disease treatments, Gilead Sciences licensed filgotinib from Galapagos NV (NASDAQ:GLPG) in 2015. 

Best Medical Stocks To Watch For 2019

Though student debt is often a necessary means to a degree, its impact can extend well beyond one’s college years. These days, a growing number of would-be homeowners are delaying that milestone because of their outstanding debt, while many workers are putting off retirement savings because their loan payments monopolize too much of their income.

But a new report from AARP contains some even more disturbing news: A frightening 16% of borrowers claim that student debt has prevented or delayed them from getting the medical care they require. This holds true for 17% of indebted millennials, 16% of Gen Xers, and 9% of baby boomers.

IMAGE SOURCE: GETTY IMAGES.

If your student loans are putting you in a position in which you’re forced to compromise your health, it’s time to ease the burden. Here’s how.

Best Medical Stocks To Watch For 2019: Woodward, Inc.(WWD)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Bloom Energy (NASDAQ: WWD) and Woodward, Inc.Common Stock (NASDAQ:WWD) are both mid-cap oils/energy companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability.

  • [By Shane Hupp]

    Woodward, Inc.Common Stock (NASDAQ:WWD) Director James R. Rulseh sold 4,112 shares of the company’s stock in a transaction on Thursday, August 2nd. The stock was sold at an average price of $79.09, for a total transaction of $325,218.08. Following the transaction, the director now owns 10,000 shares of the company’s stock, valued at approximately $790,900. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

  • [By Ethan Ryder]

    Plug Power (NASDAQ: PLUG) and Woodward (NASDAQ:WWD) are both industrial products companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Woodward, Inc.Common Stock (WWD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Medical Stocks To Watch For 2019: Perceptron, Inc.(PRCP)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Perceptron (NASDAQ: PRCP) and CyberOptics (NASDAQ:CYBE) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation.

  • [By Shane Hupp]

    Topcon (OTCMKTS: TOPCF) and Perceptron (NASDAQ:PRCP) are both small-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation.

  • [By Stephan Byrd]

    Perceptron (NASDAQ: PRCP) and II-VI (NASDAQ:IIVI) are both computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, analyst recommendations and risk.

Best Medical Stocks To Watch For 2019: Atlas Air Worldwide Holdings(AAWW)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Atlas Air Worldwide (AAWW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Atlas Air Worldwide (NASDAQ:AAWW) was downgraded by stock analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a research report issued on Wednesday.

  • [By Max Byerly]

    James Investment Research Inc. grew its position in shares of Atlas Air Worldwide Holdings, Inc. (NASDAQ:AAWW) by 124.4% during the 2nd quarter, Holdings Channel reports. The firm owned 58,875 shares of the transportation company’s stock after purchasing an additional 32,635 shares during the quarter. James Investment Research Inc.’s holdings in Atlas Air Worldwide were worth $4,221,000 at the end of the most recent quarter.

Best Medical Stocks To Watch For 2019: TherapeuticsMD, Inc.(TXMD)

Advisors’ Opinion:

  • [By Joseph Griffin]

    JPMorgan Chase & Co. initiated coverage on shares of TherapeuticsMD (NASDAQ:TXMD) in a report issued on Friday, MarketBeat Ratings reports. The brokerage issued an overweight rating and a $11.00 price target on the stock.

  • [By Lisa Levin] Gainers
    TherapeuticsMD, Inc. (NASDAQ: TXMD) rose 7.3 percent to $6.90 in pre-market trading after the company reported the FDA approval of TX-004HR: IMVEXXY (estradiol vaginal inserts) for moderate to severe dyspareunia due to menopause.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) rose 6.1 percent to $10.50 in pre-market trading after falling 1.20 percent on Tuesday
    Movado Group, Inc. (NYSE: MOV) shares rose 5.7 percent to $44.60 in pre-market trading after the company reported better-than-expected Q1 results and raised its guidance.
    salesforce.com, inc. (NYSE: CRM) rose 5.4 percent to $133.67 in pre-market trading after the company reported better-than-expected earnings for its first quarter and raised its forecast for the full year.
    Sirius XM Holdings Inc. (NASDAQ: SIRI) rose 5.3 percent to $7.35 in pre-market trading.
    PagSeguro Digital Ltd. (NYSE: PAGS) rose 5.3 percent to $33.50 in pre-market trading after reporting Q1 results.
    SpartanNash Co (NASDAQ: SPTN) rose 4.9 percent to $19.80 in pre-market trading after the company reported upbeat earnings for its first quarter on Tuesday.
    Groupon, Inc. (NASDAQ: GRPN) rose 4.9 percent to $4.95 in pre-market trading. Dalian Wanda will set up a joint venture with Tencent and Groupon's former local unit, Reuters reported.
    Okta, Inc. (NASDAQ: OKTA) rose 4.4 percent to $56 in pre-market trading after gaining 3.43 percent on Tuesday
    Elbit Systems Ltd. (NASDAQ: ESLT) rose 4.3 percent to $120.92 in pre-market trading after gaining 2.05 percent on Tuesday.
    STMicroelectronics N.V. (NYSE: STM) shares rose 3.7 percent to $23.78 in pre-market trading after falling 4.70 percent on Tuesday.
    EVINE Live Inc (NASDAQ: EVLV) shares rose 2.7 percent to $1.14 in pre-market trading after reporting Q1 results.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Max Byerly]

    TherapeuticsMD Inc (NASDAQ:TXMD) – Investment analysts at Oppenheimer increased their Q3 2018 EPS estimates for shares of TherapeuticsMD in a research report issued to clients and investors on Tuesday, June 5th. Oppenheimer analyst J. Olson now anticipates that the company will post earnings per share of ($0.08) for the quarter, up from their previous estimate of ($0.09). Oppenheimer currently has a “Buy” rating and a $12.00 price target on the stock. Oppenheimer also issued estimates for TherapeuticsMD’s Q4 2018 earnings at ($0.03) EPS, FY2018 earnings at ($0.32) EPS, FY2019 earnings at ($0.10) EPS, FY2020 earnings at $0.22 EPS, FY2021 earnings at $0.44 EPS and FY2022 earnings at $0.70 EPS.

Best Medical Stocks To Watch For 2019: Communications Systems Inc.(JCS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Cara Therapeutics, Inc. (NASDAQ: CARA) shares surged 42.76 percent to close at $16.56 on Wednesday in reaction to a new licensing agreement with Europe-based Vifor Pharma. As part of the agreement, the biopharmaceutical company that alleviates pain licensed worldwide rights (except U.S., Japan, and South Korea) to Vifor Pharma to commercialize its KORSUVA therapy to Vifor $70 million.
    Yangtze River Port and Logistics Limited (NASDAQ: YRIV) gained 31.28 percent to close at $7.05 on Wednesday.
    Tiffany & Co. (NYSE: TIF) climbed 23.29 percent to close at $126.05 after the company reported upbeat results for its first quarter and raised its FY2018 earnings guidance.
    EVO Payments, Inc. (NASDAQ: EVOP) gained 18.88 percent to close at $19.02. EVO Payments priced its IPO at $16 per share.
    Carver Bancorp, Inc. (NASDAQ: CARV) rose 16.1 percent to close at $6.85.
    USA Technologies, Inc. (NASDAQ: USAT) gained 15.68 percent to close at $13.65 after announcing pricing of public offering.
    eXp World Holdings, Inc. (NASDAQ: EXPI) shares jumped 15.01 percent to close at $17.70.
    Geron Corporation (NASDAQ: GERN) gained 14.99 percent to close at $4.68.
    Evolus, Inc. (NASDAQ: EOLS) rose 14.62 percent to close at $19.36.
    Ralph Lauren Corporation (NYSE: RL) shares rose 14.34 percent to close at $133.33 after the company reported stronger-than-expected results for its fourth quarter.
    Turtle Beach Corporation (NASDAQ: HEAR) jumped 13.26 percent to close at $17.34 on Wednesday. Turtle Beach S-3 showed registration for 1.857 million share common stock offering via selling holders.
    Communications Systems, Inc. (NASDAQ: JCS) rose 13.18 percent to close at $3.95. Communications Systems reported establishment of special committee to explore strategic alternatives.
    Immutep Limited (NASDAQ: IMMP) shares climbed 12.95 percent to close at $2.53.
    xG Technology, Inc. (NASDAQ: XGTI) rose 12.64 percent to close at $0.8561 after the company&rsq

Best Medical Stocks To Watch For 2019: Western Asset Municipal High Income Fund, Inc.(MHF)

Advisors’ Opinion:

  • [By Max Byerly]

    Vivaldi Capital Management LLC increased its stake in Western Asset Municipal (NYSE:MHF) by 64.7% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 32,185 shares of the financial services provider’s stock after purchasing an additional 12,646 shares during the quarter. Vivaldi Capital Management LLC owned about 0.15% of Western Asset Municipal worth $231,000 at the end of the most recent quarter.